Literature DB >> 7000612

Hormonal abnormalities of the pancreas and gut in cystic fibrosis.

T E Adrian, J McKiernan, D I Johnstone, E J Hiller, H Vyas, D L Sarson, S R Bloom.   

Abstract

We have investigated the effect of cystic fibrosis on alimentary hormones in 10 children by measuring the pancreatic and gut hormone rsponse to a milk drink. Plasma insulin and gastric inhibitory peptide were both significantly reduced (P < 0.05 and P < 0.005, respectively, at 15 min) in the patients with cystic fibrosis, compared with controls, even though the early glucose rise was greater in the former group (P < 0.05 at 15 min). Fasting levels of pancreatic polypeptide were significantly lower in the fibrocystic children (P < 0.01), and the normal response to milk was completely abolished in these patients (P < 0.001). Fasting plasma enteroglucagon concentrations were grossly abolished in the cystic fibrosis patients (P < 0.001) and these remained elevated throughout the test. No significant differences were seen in basal or postmilk responses of plasma glucagon, gastrin, secretin, vasoactive intestinal peptide, or motilin in cystic fibrosis. It would thus appear that the pancreatic polypeptide cell is more susceptible to the effects of the disease process than the beta or alpha cell in cystic fibrosis. Some aspects of the abnormalities in the gastrointestinal endocrine system were similar to those seen in celiac disease and tropical sprue and may, therefore, effect a similar hormonal response in these patients with cystic fibrosis to those with mucosal damage.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000612

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations.

Authors:  J De Schepper; I Dab; M P Derde; H Loeb
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

Review 2.  Small-intestinal abnormalities in cystic fibrosis patients.

Authors:  E Eggermont; K De Boeck
Journal:  Eur J Pediatr       Date:  1991-10       Impact factor: 3.183

Review 3.  Rationale of modern dietary recommendations in cystic fibrosis.

Authors:  J M Littlewood; A MacDonald
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

Review 4.  Gastrointestinal tract and nutrition in cystic fibrosis: pathophysiology.

Authors:  J A Dodge
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

Review 5.  Recent advances in pancreatic hormone research.

Authors:  R G Long
Journal:  Postgrad Med J       Date:  1983-05       Impact factor: 2.401

Review 6.  Cystic fibrosis--a gastroenterological cornucopia.

Authors:  P L Zentler-Munro
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

Review 7.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 4. Tests involving the measurement of pancreatic enzymes in body fluid.

Authors:  E J Boyd; H Rinderknecht; K G Wormsley
Journal:  Int J Pancreatol       Date:  1988 Jan-Feb

8.  Meconium ileus equivalent in older patients with cystic fibrosis.

Authors:  P L Zentler-Munro; M E Hodson; J C Batten
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-13

9.  Pancreatic polypeptide secretion. A marker for disturbed pancreatic function in cystic fibrosis.

Authors:  A Stern; G P Davidson; C P Kirubakaran; J Deutsch; A Smith; J Hansky
Journal:  Dig Dis Sci       Date:  1983-10       Impact factor: 3.199

10.  Gut hormones and gastrointestinal motility in children with cystic fibrosis.

Authors:  M S Murphy; A L Brunetto; A D Pearson; M A Ghatei; R Nelson; E J Eastham; S R Bloom; A A Green
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.